Adenoviral vector-based strategies against infectious disease and cancer

Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102 · see citing works

An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C. C., Horn, S. T., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,753 · see citing works

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713 · see citing works

Ebola haemorrhagic fever

Feldmann, H., & Geisbert, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,369 · see citing works

A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

Khuri, F. R., Nemunaitis, J. J., Ganly, I., Arseneau, J. C., Tannock, I. F., Romel, L., Gore, M. E., Ironside, J. A. D., MacDougall, R. H., Heise, C. C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,099 · see citing works

CD46 is a cellular receptor for group B adenoviruses

Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793 · see citing works

Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo

Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi‐Hebenstreit, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1991) · Science · doi:10.1126/science.2017680 · Cited by 736 · see citing works

Adenoviruses as vaccine vectors

Tatsis, N., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.013 · Cited by 669 · see citing works

The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F

Roelvink, P. W., Lizonová, A., Lee, J. G. M., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I., & Wickham, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7909-7915.1998 · Cited by 655 · see citing works

Development of a preventive vaccine for Ebola virus infection in primates

Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655 · see citing works

Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

Hammer, S. M., Sobieszczyk, M. E., Janes, H., Karuna, S., Mulligan, M. J., Grove, D., Koblin, B. A., Buchbinder, S., Keefer, M. C., Tomaras, G. D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310566 · Cited by 597 · see citing works

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 464 · see citing works

Developments in Viral Vector-Based Vaccines

Ura, T., Okuda, K., & Shimada, M. (2014) · Vaccines · doi:10.3390/vaccines2030624 · Cited by 437 · see citing works

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14

Wang, H., Li, Z.-Y., Liu, Y., Persson, J., Beyer, I., Möller, T., Koyuncu, D., Drescher, M. R., Strauss, R., Zhang, X., et al. (2010) · Nature Medicine · doi:10.1038/nm.2270 · Cited by 436 · see citing works

Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein Networks

Liu, H., Jin, L., Koh, S. B. S., Atanasov, I. C., Schein, S., Wu, L., & Zhou, Z. H. (2010) · Science · doi:10.1126/science.1187433 · Cited by 384 · see citing works

A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA

Ewer, K., Rampling, T., Venkatraman, N., Bowyer, G., Wright, D., Lambe, T., Imoukhuede, E. B., Payne, R., Fehling, S. K., Strecker, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1411627 · Cited by 348 · see citing works

Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues

Crawford-Miksza, L. K., & Schnurr, D. P. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1836-1844.1996 · Cited by 326 · see citing works

Ebola virus: from discovery to vaccine

Feldmann, H., Jones, S. J. M., Klenk, H., & Schnittler, H. (2003) · Nature reviews. Immunology · doi:10.1038/nri1154 · Cited by 308 · see citing works

Chimpanzee Adenovirus Vector Ebola Vaccine

Ledgerwood, J. E., DeZure, A. D., Stanley, D. A., Coates, E. E., Novik, L., Enama, M. E., Berkowitz, N. M., Hu, Z., Joshi, G., Ploquin, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1410863 · Cited by 286 · see citing works

Crystal structure of the receptor-binding domain of adenovirus type 5 fiberprotein at 1.7 Å resolution

Xia, D., Henry, L. J., Gerard, R. D., & Deisenhofer, J. (1994) · Structure · doi:10.1016/s0969-2126(94)00126-x · Cited by 270 · see citing works

Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

Gao, W., Soloff, A. C., Lu, X., Montecalvo, A., Nguyen, D. C., Matsuoka, Y., Robbins, P. D., Swayne, D. E., Donis, R. O., Katz, J. M., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1959-1964.2006 · Cited by 270 · see citing works

New Insights on Adenovirus as Vaccine Vectors

Lasaro, M. O., & Ertl, H. C. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.130 · Cited by 263 · see citing works

Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli

Henry, L. J., Xia, D., Wilke, M. E., et al. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5239-5246.1994 · Cited by 250 · see citing works

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

Ledgerwood, J. E., Sullivan, N. J., & Graham, B. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1505499 · Cited by 247 · see citing works

Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial

Westphal, M., Ylä‐Herttuala, S., Martin, J. F., Warnke, P. C., Meneï, P., Eckland, D. J. A., Kinley, J., Kay, R., & Ram, Z. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70274-2 · Cited by 239 · see citing works

Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells

Huang, S., Kamata, T., Takada, Y., Ruggeri, Z. M., & Nemerow, G. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4502-4508.1996 · Cited by 238 · see citing works

The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis

Nilsson, E., Storm, R., Bauer, J., Johansson, S., Lõokene, A., Ångström, J., Hedenström, M., Eriksson, T., Frängsmyr, L., Rinaldi, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2267 · Cited by 225 · see citing works

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

Sullivan, N. J., Hensley, L. E., Asiedu, C. K., Geisbert, T. W., Stanley, D. A., Johnson, J. C., Honko, A. N., Olinger, G. G., Bailey, M., Geisbert, J. B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2447 · Cited by 225 · see citing works

Latent Species C Adenoviruses in Human Tonsil Tissues

Garnett‐Benson, C., Talekar, G. R., Mahr, J. A., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02392-08 · Cited by 225 · see citing works

Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

Geisbert, T. W., Bailey, M., Hensley, L. E., Asiedu, C. K., Geisbert, J. B., Stanley, D. A., Honko, A. N., Johnson, J. C., Mulangu, S., Pau, M. G., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02407-10 · Cited by 224 · see citing works

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans

Kampen, K. R. V., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D., Marks, D. H., Elmets, C. A., & Tang, D.-C. C. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.043 · Cited by 220 · see citing works

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

Tapia, M. D., Sow, S. O., Lyke, K. E., Haidara, F. C., Diallo, F., Doumbia, M. M., Traoré, A., Coulibaly, F., Kodio, M., Onwuchekwa, U., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00362-x · Cited by 219 · see citing works

ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans

Hodgson, S. H. C., Duncan, C. J. A., Elias, S. C., Choudhary, P., Biswas, S., Halstead, F. D., Collins, K. A., Edwards, N. J., Douglas, A. D., Anagnostou, N. A., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.223 · Cited by 212 · see citing works

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

Ledgerwood, J. E., Costner, P. J. M., Desai, N., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.037 · Cited by 210 · see citing works

Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs.

Wickham, T. J., Carrion, M. E., & Kovesdi, I. (1995) · PubMed · Cited by 210 · see citing works

A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity

Smaill, F., Jeyanathan, M., Smieja, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006843 · Cited by 204 · see citing works

Adenovirus receptors: implications for targeting of viral vectors

Arnberg, N. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.005 · Cited by 201 · see citing works

RGD Inclusion in the Hexon Monomer Provides Adenovirus Type 5-Based Vectors with a Fiber Knob-Independent Pathway for Infection

Vigne, E., Mahfouz, I., Dedieu, J.-F., Brie, A., Perricaudet, M., & Yeh, P. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5156-5161.1999 · Cited by 191 · see citing works

High-Capacity Adenoviral Vectors for Gene Transfer and Somatic Gene Therapy

Kochanek, S. (1999) · Human Gene Therapy · doi:10.1089/10430349950016807 · Cited by 173 · see citing works

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

Gray, G., Buchbinder, S., & Duerr, A. C. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833d2d2b · Cited by 172 · see citing works

Expression of the Primary Coxsackie and Adenovirus Receptor Is Downregulated during Skeletal Muscle Maturation and Limits the Efficacy of Adenovirus-Mediated Gene Delivery to Muscle Cells

Nalbantoglu, J. N., Pari, G., Karpati, G., & Holland, P. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950018409 · Cited by 169 · see citing works

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

Baden, L. R., Walsh, S. R., Seaman, M. S., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis670 · Cited by 166 · see citing works

Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients

Liikanen, I., Ahtiainen, L., Hirvinen, M., Bramante, S., Cerullo, V., Nokisalmi, P., Hemminki, O., Diaconu, I., Pesonen, S. A., Koski, A., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.51 · Cited by 165 · see citing works

Engineering of Adenovirus Vectors Containing Heterologous Peptide Sequences in the C Terminus of Capsid Protein IX

Dmitriev, I. P., Kashentseva, E. A., & Curiel, D. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6893-6899.2002 · Cited by 164 · see citing works

Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells

Perreau, M., Pantaleo, G., & Kremer, E. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081786 · Cited by 163 · see citing works

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

Gurwith, M., Lock, M. D., Taylor, E. M., Ishioka, G. Y., Alexander, J., Mayall, T., Ervin, J. E., Greenberg, R. N., Strout, C. B., Treanor, J. J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70345-6 · Cited by 157 · see citing works

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1

Benlahrech, A., Harris, J. D., Meiser, A., Papagatsias, T., Hornig, J., Hayes, P., Lieber, A., Athanasopoulos, T., Bachy, V. S., Csomor, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907898106 · Cited by 153 · see citing works

VEGF-specific Short Hairpin RNA–expressing Oncolytic Adenovirus Elicits Potent Inhibition of Angiogenesis and Tumor Growth

Yoo, J. Y., Kim, J.-H., Kwon, Y., Kim, E.-C., Kim, N. K., Choi, H. J., & Yun, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300023 · Cited by 149 · see citing works

A Recombinant Human Adenovirus Vaccine against Rabies

PREVEC, L., Campbell, J. B., Christie, B. S., Belbeck, L. W., & Graham, F. L. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.1.27 · Cited by 147 · see citing works

Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX

Colby, W. W., & Shenk, T. E. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.977-980.1981 · Cited by 145 · see citing works

Introduction of Mobile Health Tools to Support Ebola Surveillance and Contact Tracing in Guinea

Sacks, J. A., Zehe, E., Redick, C., Bah, A., Cowger, K., Camara, M., Diallo, A., Gigo, A. N. I., Dhillon, R. S., & Liu, A. (2015) · Global Health Science and Practice · doi:10.9745/ghsp-d-15-00207 · Cited by 143 · see citing works

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

Chuang, I., Sedegah, M., Cicatelli, S., Spring, M., Polhemus, M. E., Tamminga, C. L., Patterson, N. B., Guerrero, M. L., Bennett, J. W., McGrath, S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055571 · Cited by 141 · see citing works

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

Frahm, N., deCamp, A. C., Friedrich, D. P., Carter, D. K., Defawe, O., Kublin, J. G., Casimiro, D. R., Duerr, A. C., Robertson, M. N., Buchbinder, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci60202 · Cited by 141 · see citing works

A quasi‐atomic model of human adenovirus type 5 capsid

Fabry, C. M. S., Rosa‐Calatrava, M., Conway, J. F., Zubieta, C., Cusack, S., Ruigrok, R. W. H., & Schoehn, G. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600653 · Cited by 141 · see citing works

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

Xiang, Z., Gao, G., Reyes‐Sandoval, A., Li, Y., Wilson, J. M., & Ertl, H. C. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.10780-10789.2003 · Cited by 140 · see citing works

A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)

Churchyard, G., Morgan, C. A., Adams, E. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021225 · Cited by 139 · see citing works

Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector

Toietta, G., Mane, V. P., Norona, W. S., Finegold, M. J., Ng, P., McDonagh, A. F., Beaudet, A. L., & Lee, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500930102 · Cited by 139 · see citing works

Receptor Interactions Involved in Adenoviral-Mediated Gene Delivery After Systemic Administration in Non-Human Primates

Smith, T. A., Idamakanti, N., Marshall-Neff, J., Rollence, M. L., Wright, P., Kaloss, M., King, L., Mech, C. A., Dinges, L., Iverson, W. O., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322542248 · Cited by 138 · see citing works

Adenovirus Protein V Induces Redistribution of Nucleolin and B23 from Nucleolus to Cytoplasm

Matthews, D. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.1031-1038.2001 · Cited by 137 · see citing works

Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice

Kim, E., Okada, K., Kenniston, T., Raj, V. S., AlHajri, M. M., Farag, E., Alhajri, F. H., Osterhaus, A. D. M. E., Haagmans, B. L., & Gambotto, A. A. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.058 · Cited by 135 · see citing works

Visualization of α-Helices in a 6-Angstrom Resolution Cryoelectron Microscopy Structure of Adenovirus Allows Refinement of Capsid Protein Assignments

Saban, S. D., Silvestry, M., Nemerow, G. R., & Stewart, P. L. (2006) · Journal of Virology · doi:10.1128/jvi.01652-06 · Cited by 134 · see citing works

Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses

Koup, R. A., Roederer, M., Lamoreaux, L., Fischer, J., Novik, L., Nason, M., Larkin, B. D., Enama, M. E., Ledgerwood, J. E., Bailer, R. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009015 · Cited by 133 · see citing works

Integrin alpha5beta1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16

Davison, E., Diaz, R. M., Hart, I. R., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.6204-6207.1997 · Cited by 130 · see citing works

Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys

Teigler, J. E., Iampietro, M. J., & Barouch, D. H. (2012) · Journal of Virology · doi:10.1128/jvi.00740-12 · Cited by 129 · see citing works

A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry

Wodrich, H., Henaff, D., Baptist, J., Segura-Morales, C., Seelmeir, S., Coux, O., Ruzsics, Z., Wiethoff, C. M., & Kremer, E. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000808 · Cited by 128 · see citing works

Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit

Yeh, P., Dedieu, J.-F., Orsini, C., Vigne, E., Denèfle, P., & Perricaudet, M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.559-565.1996 · Cited by 125 · see citing works

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus

Raviprakash, K. S., Wang, D., Ewing, D. F., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02724-07 · Cited by 125 · see citing works

Tumor Necrosis Factor-α Induces Bax-Bak Interaction and Apoptosis, Which Is Inhibited by Adenovirus E1B 19K

Sundararajan, R., Cuconati, A., Nelson, D. A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106386200 · Cited by 123 · see citing works

Insights into adenovirus host cell interactions from structural studies

Nemerow, G. R., Pache, L., Reddy, V. S., & Stewart, P. L. (2008) · Virology · doi:10.1016/j.virol.2008.10.016 · Cited by 123 · see citing works

Evolution of oncolytic adenovirus for cancer treatment

Choi, J.-W., Lee, J. S., Kim, S. W., et al. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.011 · Cited by 121 · see citing works

Structure-Based Identification of a Major Neutralizing Site in an Adenovirus Hexon

Pichla-Gollon, S. L., Drinker, M. S., Zhou, X., Xue, F., Rux, J. J., Gao, G., Wilson, J. M., Ertl, H. C. J., Burnett, R. M., & Bergelson, J. M. (2006) · Journal of Virology · doi:10.1128/jvi.02023-06 · Cited by 115 · see citing works

Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancer

Sachs, M. D., Rauen, K. A., Ramamurthy, M., et al. (2002) · Urology · doi:10.1016/s0090-4295(02)01748-x · Cited by 113 · see citing works

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector‐based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus

Guo, X., Deng, Y. L., Chen, H., Lan, J., Wang, W., Zou, X., Hung, T., Lu, Z., & Tan, W. (2015) · Immunology · doi:10.1111/imm.12462 · Cited by 112 · see citing works

Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)

Barouch, D. H., Liu, J., Peter, L. E., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis671 · Cited by 108 · see citing works

Computational Analysis of Two Species C Human Adenoviruses Provides Evidence of a Novel Virus

Walsh, M. P., Seto, J., Liu, E. B., Dehghan, S., Hudson, N. R., Lukashev, A. N., Ivanova, O. E., Chodosh, J., Dyer, D. W., Jones, M. S., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00156-11 · Cited by 107 · see citing works

Adenovirus Structure

Rux, J. J., & Burnett, R. M. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1167 · Cited by 106 · see citing works

Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts

Fuxe, J., Liu, L., Malin, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10891 · Cited by 104 · see citing works

Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment

Roelvink, P. W., Kovesdi, I., & Wickham, T. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7614-7621.1996 · Cited by 100 · see citing works

Adenovirus Protein IX: A New Look at an Old Protein

Parks, R. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.018 · Cited by 99 · see citing works

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity

Hoft, D. F., Blazevic, A., Stanley, J., Landry, B., Sizemore, D. R., Kpamegan, E. P., Gearhart, J., Scott, A. J., Kik, S. V., Pau, M. G., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.048 · Cited by 94 · see citing works

Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck

Nemunaitis, J. J., Clayman, G. L., Agarwala, S. S., Hrushesky, W. J. M., Wells, J. R., Moore, C. E., Hamm, J. T., Yoo, G. H., Baselga, J. M., Murphy, B. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1044 · Cited by 91 · see citing works

High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial

Liebowitz, D. N., Lindbloom, J. D., Brandl, J. R., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00266-2 · Cited by 89 · see citing works

Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+ T Cells Induced by Different Adenovirus Vectors

Tan, W., Jin, H., West, E., Penaloza-MacMaster, P., Wieland, A., Zilliox, M. J., McElrath, M., Barouch, D., & Ahmed, R. (2012) · Journal of Virology · doi:10.1128/jvi.02055-12 · Cited by 88 · see citing works

Characterization of the adenovirus 2 virion protein, Mu

Anderson, C. W., Young, M. E., & Flint, S. J. (1989) · Virology · doi:10.1016/0042-6822(89)90193-1 · Cited by 87 · see citing works

Adenovirus Core Protein VII Protects the Viral Genome from a DNA Damage Response at Early Times after Infection

Karen, K. A., & Hearing, P. (2011) · Journal of Virology · doi:10.1128/jvi.02540-10 · Cited by 85 · see citing works

Simultaneous Administration of Live, Enteric-Coated Adenovirus Types 4,7, and 21 Vaccines: Safety and Immunogenicity

Takafuji, E. T., Gaydos, J. C., Allen, R. G., et al. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/140.1.48 · Cited by 84 · see citing works

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Keefer, M. C., Gilmour, J. W., Hayes, P., Gill, D. K., Kopycinski, J. T., Cheeseman, H. M., Cashin‐Cox, M., Naarding, M. A., Clark, L., Fernández, N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041936 · Cited by 83 · see citing works

Large, Persistent Epidemic of Adenovirus Type 4-Associated Acute Respiratory Disease in U.S. Army Trainees

McNeill, K. M., Hendrix, R. M., Lindner, J. L., et al. (1999) · Emerging infectious diseases · doi:10.3201/eid0506.990609 · Cited by 80 · see citing works

Epitopes Expressed in Different Adenovirus Capsid Proteins Induce Different Levels of Epitope-Specific Immunity

Krause, A., Joh, J., Hackett, N. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.02667-05 · Cited by 72 · see citing works

Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin

Gilbert, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg141 · Cited by 71 · see citing works

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans

Peters, W., Brandl, J. R., Lindbloom, J. D., Martínez, C., Scallan, C. D., Trager, G. R., Tingley, D. W., Kabongo, M. L., & Tucker, S. N. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.023 · Cited by 69 · see citing works

Adenovirus Protein VII Condenses DNA, Represses Transcription, and Associates with Transcriptional Activator E1A

Johnson, J. S., Osheim, Y. N., Xue, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6459-6468.2004 · Cited by 69 · see citing works

A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

Wolf, J. K., Bodurka, D. C., Gano, J. B., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.05.041 · Cited by 67 · see citing works

Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans

Baden, L. R., Liu, J., Li, H., Johnson, J. A., Walsh, S. R., Kleinjan, J. A., Engelson, B. A., Peter, L. E., Abbink, P., Milner, D. A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu485 · Cited by 66 · see citing works

An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity

Khanam, S., Pilankatta, R., Khanna, N., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.073 · Cited by 65 · see citing works

Head and neck cancer: Response to p53‐based therapeutics

Nemunaitis, J., & Nemunaitis, J. J. (2010) · Head & Neck · doi:10.1002/hed.21364 · Cited by 65 · see citing works

Adenovirus Protein VII Functions throughout Early Phase and Interacts with Cellular Proteins SET and pp32

Xue, Y., Johnson, J. S., Ornelles, D. A., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2474-2483.2005 · Cited by 65 · see citing works

Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2

Jaiswal, S., Khanna, N., & Swaminathan, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12907-12913.2003 · Cited by 65 · see citing works

Protection of non-human primates against rabies with an adenovirus recombinant vaccine

Xiang, Z., Greenberg, L., Ertl, H. C. J., et al. (2014) · Virology · doi:10.1016/j.virol.2013.12.029 · Cited by 59 · see citing works

Adenovirus Type 9 Fiber Knob Binds to the Coxsackie B Virus-Adenovirus Receptor (CAR) with Lower Affinity than Fiber Knobs of Other CAR-Binding Adenovirus Serotypes

Kirby, I., Lord, R., Davison, E., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7210-7214.2001 · Cited by 58 · see citing works

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age

Ouédraogo, A., Tiono, A. B., Kargougou, D. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078679 · Cited by 55 · see citing works

A Single Sublingual Dose of an Adenovirus-Based Vaccine Protects against Lethal Ebola Challenge in Mice and Guinea Pigs

Choi, J. H., Schafer, S. C., Zhang, L., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200392g · Cited by 55 · see citing works

Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China

Wang, X., Xing, M., Zhang, C., et al. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.30 · Cited by 54 · see citing works

Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness

Vemula, S. V., Ahi, Y. S., Swaim, A.-M., Katz, J. M., Donis, R. O., Sambhara, S. R., & Mittal, S. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062496 · Cited by 52 · see citing works

Single-Molecule Analysis of the Target Cleavage Reaction by the Drosophila RNAi Enzyme Complex

Yao, C., Sasaki, H. M., Ueda, T., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.015 · Cited by 51 · see citing works

Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by ?v?1 integrin and can be modulated by changes in ?1 integrin function

Davison, E., Kirby, I., Whitehouse, J. L., et al. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.223 · Cited by 51 · see citing works

Localization of the N-Terminus of Minor Coat Protein IIIa in the Adenovirus Capsid

Martı́n, C. S., Glasgow, J. N., Borovjagin, A. V., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.054 · Cited by 46 · see citing works

Serum‐free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity

Havenga, M. J. E., Holterman, L., Melis, I., Smits, S., Kaspers, J., Heemskerk, E., van der Vlugt, R., Koldijk, M. H., Schouten, G. J., Hateboer, G., et al. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21757 · Cited by 44 · see citing works

Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration

Vos, A. C., Neubert, A., Pommerening, E., Müller, T., Döhner, L., Neubert, L., & Hughes, K. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-9-2191 · Cited by 42 · see citing works

Human adenovirus 5-vectoredPlasmodium falciparumNMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection

Tamminga, C. L., Sedegah, M., Maiolatesi, S. E., Fedders, C., Reyes, S., Reyes, A. E., Vásquez, C., Alcorta, Y., Chuang, I., Spring, M., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24941 · Cited by 39 · see citing works

Prime-Boost Vaccination with rBCG/rAd35 Enhances CD8+ Cytolytic T-Cell Responses in Lesions from Mycobacterium Tuberculosis-Infected Primates

Rahman, S., Magalhaes, I., Rahman, J., Ahmed, R. K. S., Sizemore, D. R., Scanga, C. A., Weichold, F., Verreck, F. A. W., Kondova, I. I., Sadoff, J., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00222 · Cited by 37 · see citing works

Efficient species C HAdV infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/caveola endocytic route

Colin, M., Mailly, L., Rogée, S., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.007 · Cited by 37 · see citing works

The Life and Times of Adenoviruses

Ginsberg, H. S. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60363-2 · Cited by 36 · see citing works

Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa

Sharma, A., Krause, A., Xu, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056996 · Cited by 36 · see citing works

Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon

Tian, X., Su, X., Li, X., Li, H., Li, T., Zhou, Z., Zhong, T., & Zhou, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041381 · Cited by 35 · see citing works

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species

Dicks, M. D. J., Guzman, E., Spencer, A. J., Gilbert, S. C., Charleston, B., Hill, A. V. S., & Cottingham, M. G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.01.042 · Cited by 33 · see citing works

Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1

Ugai, H., Dobbins, G. C., Wang, M., Le, L. P., Matthews, D. A., & Curiel, D. T. (2012) · Virology · doi:10.1016/j.virol.2012.05.028 · Cited by 33 · see citing works

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

Janes, H. E., Frahm, N., deCamp, A. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043396 · Cited by 33 · see citing works

Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep

Bouet-Cararo, C., Contreras, V., Fournier, A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.068 · Cited by 27 · see citing works

Hexon-modified Recombinant E1-deleted Adenovirus Vectors as Dual Specificity Vaccine Carriers for Influenza Virus

Zhou, D., Wu, T.-L., Emmer, K. L., Kurupati, R. K., Tuyishime, S., Li, Y., Giles‐Davis, W., Zhou, X., Xiang, Z., Liu, Q., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.248 · Cited by 26 · see citing works

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization

Khurana, S., Coyle, E. M., Manischewitz, J. F., King, L. R., Ishioka, G. Y., Alexander, J., Smith, J., Gurwith, M., & Golding, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115476 · Cited by 25 · see citing works

Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models

Chi, Y., Wang, X., Yang, Y. P., et al. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.59 · Cited by 25 · see citing works

Enhanced antitumor efficacy of fiber‐modified, midkine promoter‐regulated oncolytic adenovirus in human malignant mesothelioma

Takagi‐Kimura, M., Yamano, T., Tamamoto, A., Okamura, N., Okamura, H., Hashimoto‐Tamaoki, T., Tagawa, M., Kasahara, N., & Kubo, S. (2013) · Cancer Science · doi:10.1111/cas.12267 · Cited by 24 · see citing works

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals

Fuchs, J. D. (2015) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000461 · Cited by 24 · see citing works

Centralized Consensus Hemagglutinin Genes\nInduce Protective Immunity against H1, H3\nand H5 Influenza Viruses

Webby, R. J., & Weaver, E. A. (2015) · Lincoln (University of Nebraska) · Cited by 23 · see citing works

Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice

Li, W., LI, M., Deng, G., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3770 · Cited by 22 · see citing works

Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge

Zhang, H., Tang, X., Zhu, C., Song, Y., Yin, J., Xu, J., Ertl, H. C. J., & Zhou, D. (2015) · Gene Therapy · doi:10.1038/gt.2015.31 · Cited by 22 · see citing works

Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates

Wong, G., Richardson, J. S., Pillet, S., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv102 · Cited by 21 · see citing works

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1

Schwenk, R., Banania, G. J., Epstein, J., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-376 · Cited by 20 · see citing works

Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development

Cheng, C., Wang, L., Ko, S., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.023 · Cited by 19 · see citing works

Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals

Wong, G., Richardson, J. S., Cutts, T. A., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.001 · Cited by 19 · see citing works

HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice

MacLeod, S. H., Elgadi, M., Bossi, G., Sankar, U., Pisio, A. C., Agopsowicz, K. C., Sharon, D. M., Graham, F. L., & Hitt, M. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.79 · Cited by 19 · see citing works

Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71

Zhang, C., Yang, Y., Chi, Y., et al. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.08.016 · Cited by 18 · see citing works

AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer

Nie, B., Shen, Z., Wen, J.-B., Wong, O. G., Hsueh, W. D., Huo, L.-F., Kung, H., Jiang, B., & Lin, M. C. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0366 · Cited by 18 · see citing works

Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors

de Vrij, J., van den Hengel, S. K., Uil, T. G., et al. (2010) · Virology · doi:10.1016/j.virol.2010.10.040 · Cited by 13 · see citing works

Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer

Wu, J., Zhu, Y., XU, C., Xu, H., Zhou, X., Yang, J., Xie, Y., & Tao, M. (2015) · Oncology Reports · doi:10.3892/or.2015.4385 · Cited by 13 · see citing works

A Replicating Adenovirus Capsid Display Recombinant Elicits Antibodies against Plasmodium falciparum Sporozoites in Aotus nancymaae Monkeys

Karen, K. A., Deal, C. E., Adams, R. J., Nielsen, C. M., Ward, C., Espinosa, D. A., Xie, J., Zavala, F. P., & Ketner, G. W. (2014) · Infection and Immunity · doi:10.1128/iai.02626-14 · Cited by 13 · see citing works

Recent developments in clinical trial designs for HIV vaccine research

Richert, L. E., Lhomme, É., Fagard, C., Lévy, Y., Chêne, G., & Thiébaut, R. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1011974 · Cited by 11 · see citing works

A fiber-modified adenovirus co-expressing HSV-TK and Coli.NTR enhances antitumor activities in breast cancer cells.

Zhan, Y., Yu, B., Wang, Z., Zhang, Y., Zhang, H., Wu, H., Feng, X., Geng, R., Kong, W., & Yu, X. (2014) · PubMed Central · Cited by 8 · see citing works

In vitro antitumor immune response induced by dendritic cells transduced with human livin α recombinant adenovirus

Xie, J., Guo, X., Liu, F., et al. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.06.003 · Cited by 5 · see citing works

The induction of antigen-specific CTL by in situ Ad-REIC gene therapy

Ariyoshi, Y., Watanabe, M., Eikawa, S., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.7 · Cited by 5 · see citing works

Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses

Webby, R. J., & Weaver, E. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140702

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Logunov, D. Y., Dolzhikova, I. V., Shcheblyakov, D. V., Tukhvatulin, A. I., Zubkova, O. V., Dzharullaeva, A. S., Kovyrshina, A. V., Lubenets, N. L., Grousova, D. M., Erokhova, A. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00234-8 · Cited by 1,747 · see citing works

Viral vector platforms within the gene therapy landscape

Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404 · see citing works

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31866-3 · Cited by 1,055 · see citing works

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Wang, H., Zhang, Y., Huang, B., Deng, W., Quan, Y., Wang, W., Xu, W., Zhao, Y., Li, N., Zhang, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.008 · Cited by 748 · see citing works

Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges

Ghosh, S., Brown, A. M., Jenkins, C., & Campbell, K. (2020) · Applied Biosafety · doi:10.1177/1535676019899502 · Cited by 218 · see citing works

[Improvements of lentiviral vector and its application in gene therapy of hematological diseases].

Zhu, H., & Xu, K. (2003) · PubMed

501. Porcine Adenoviral Vectors as Promising Supplement to Human Adenoviral Vectors for Gene Therapy

(2003) · Molecular Therapy · doi:10.1016/s1525-0016(16)40943-3

Opportunities for the Use of Lentiviral Vectors in Human Gene Therapy

Galimi, F., & Verma, I. M. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56114-6_13 · Cited by 70 · see citing works

Cell‐selective viral gene delivery vectors for the vasculature

Baker, A. H., Kritz, A., Work, L. M., et al. (2004) · Experimental Physiology · doi:10.1113/expphysiol.2004.028126 · Cited by 37 · see citing works

Gene therapy for cardiovascular applications

Pacak, C. A., Mah, C. S., & Byrne, B. J. (2005) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(05)31009-6